A novel quantitative PET- and MRI-based imaging approach can objectively identify a recently recognized type of ...

PET and MRI scans may together distinguish a new type of dementia from Alzheimer’s disease (AD), a 2026 retrospective, ...

A novel quantitative PET- and MRI-based imaging approach can objectively identify a recently recognized type of dementia--limbic-predominant age-related TDP-43 encephalopathy, or LATE--that is often ...

Inflammation in former football players was tied to limbic white matter damage and worse memory, revealing a potential pathway linking repetitive head impacts to later cognitive decline.

Proposed clinical criteria for a memory loss disorder that is often misdiagnosed as Alzheimer's disease (AD), have been published. The new criteria for limbic-predominant amnestic neurodegenerative ...

Older adults are increasingly being diagnosed with limbic-predominant age-related TDP-43 encephalopathy (LATE) dementia. This is in part due to new guidelines advising doctors how to identify the ...

A new type of degenerative brain disease, limbic-predominant age-related TDP-43 encephalopathy (LATE), was recognised just a decade or so ago, and remains relatively unknown. In the disease, the ...

Penn Medicine-led research outlines criteria for limbic-predominant age-related TDP-43 encephalopathy, advancing clinical trials and treatment options for this common but underdiagnosed memory-loss ...

Catholic nuns don't make a habit of participating in long-term studies on aging and dementia, but one notable exception has yielded critical insights into cognitive resilience, neuropathology and ...

BALTIMORE — The anti-interleukin-6 (IL-6) antibody drug tocilizumab shows efficacy in the treatment of patients with autoimmune limbic encephalitis (ALE) who do not respond to rituximab, new research ...